CLINICAL_TRIALS
trial_result
· 2015-10-05
Clinical Trial Update: A Pharmacokinetic Study of RO5185426 in Combination With a Drug Cocktail in Patients With Metastatic Melanoma [Phase 1]
Summary
Phase 1 pharmacokinetic study of RO5185426 in combination with a drug cocktail in patients with metastatic melanoma; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Malignant Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2015-10-05